Efficacy and safety of low-intensity chemotherapy combined with immunotherapy in elderly patients with locally advanced and metastatic non–small cell lung cancer: a retrospective analysis

Abstract For advanced non-small cell lung cancer (NSCLC) lacking driver mutations, immunotherapy combined with chemotherapy is a standard treatment; however, elderly patients frequently exhibit poor tolerance to standard chemotherapy and derive limited benefit from immunotherapy alone. Thus, this re...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yunye Mao, An Wang, Boyu Qin, Jinzhao Zhai, Xiangwei Ge, Shu Sheng, Yi Hu, Jinliang Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-04-01
coleção:	BMC Cancer
Assuntos:	Elderly patients Non–small cell lung cancer Immunotherapy Low-intensity chemotherapy
Acesso em linha:	https://doi.org/10.1186/s12885-026-15943-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!